Coventry University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University College London Featured PhD Programmes
University College London Featured PhD Programmes
Cardiff University Featured PhD Programmes
"recombinant"×
10 miles

Cell Biology / Development (recombinant) PhD Projects, Programs & Scholarships

We have 31 Cell Biology / Development (recombinant) PhD Projects, Programs & Scholarships

  • "recombinant" ×
  • Cell Biology / Development×
  • clear all
Order by 
Showing 1 to 10 of 31
  Cross presentation of antigens of recombinant overlapping peptides to optimise vaccines against tumour and infectious diseases
  Dr S Jiang, Dr N Burgess-Brown
Application Deadline: 4 December 2019

Funding Type

PhD Type

THE PROJECT. We have developed a technology to producing overlapping peptides - bacterial expression of an amino acid sequence corresponding to overlapping peptide sequences spanning the length of a protein of interest interspersed with enzymatic cleavage sites.
  Rational engineering of NMDAR subunit-specific peptide affinity reagents and their pharmacological and functional characterisation as novel subtype specific NMDAR ligands.
  Dr M Soloviev
Applications accepted all year round

Funding Type

PhD Type

The aim of this project is to engineer subunit-specific anti-GluN1/2/A/B polypeptide affinity reagents and to characterise their pharmacological specificity and functional activity on the recombinant NMDARs expressed in heterologous expression systems and on native NMDARs in hippocampal slice preparations.
  EASTBIO: Understanding the pathogenesis of life-threatening Burkholderia cenocepacia infections using blocking antibodies and novel chemistry scaffolds to untangle complex aspects of AMR
  Prof A Porter, Dr S Palliyil, Prof M Jaspars
Application Deadline: 5 January 2020

Funding Type

PhD Type

Supervisors. Professor Andy Porter (University of Aberdeen). https://www.abdn.ac.uk/people/a.porter. Dr Soumya Palliyil (University of Aberdeen).
  Development of functionalised exosomes for personalised precision medicine in the treatment of cancer - a nanomedicine platform
  Research Group: Biomedical Research Group
  Dr P Dyer, Dr C O'Kane, Prof C Parris
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  The investigation of a novel peptide delivery platform for the manipulation of platelet function
  Research Group: Biomedical Research Group
  Dr P Dyer, Dr N Pugh
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Antibody-drug conjugates (ADCs) for the treatment of solid tumours
  Dr S Karagiannis, Prof J Downward
Application Deadline: 29 November 2019

Funding Type

PhD Type

An Antibody-Drug Conjugate (ADC) comprises an antibody targeted toward a tumour cell surface antigen, coupled through a chemical linker to a highly-cytotoxic drug.
  (BBSRC DTP) Mechanism of early steps in protein synthesis by cryoEM imaging of supramolecular complexes
  Dr A Roseman, Prof G D Pavitt, Prof C Baldock
Application Deadline: 31 January 2020

Funding Type

PhD Type

The aim of this project is to understand the mechanism and control of protein synthesis in eukaryotic cells at the molecular level, particularly focused around the role of the eukaryotic translation initiation factors eIF2, eIF5 and eIF2B.
  (BBSRC DTP) Understanding structure and function of the mechanosensors talin and vinculin
  Dr C Ballestrem, Prof C Baldock, Dr A Roseman
Application Deadline: 31 January 2020

Funding Type

PhD Type

The ability of cells to sense biochemical and mechanical properties of their extracellular matrix (ECM) environment is critical for the development of functional tissue.
  Cutting off the fuel supply to calcium pumps in pancreatic cancer: a novel therapeutic strategy
  Dr J Bruce, Prof K Williams, Dr A P Gilmore
Applications accepted all year round

Funding Type

PhD Type

Background and Rationale. Pancreatic ductal adenocarcinoma (PDAC) has the poorest survival and limited treatment options. Therefore, the search for novel therapeutic targets and drugs designed to selectively kill PDAC cells must remain a central research strategy.
  Stress regulation of protein translation: role in cancer and neurodegeneration
  Dr A J Whitmarsh, Prof M Ashe
Applications accepted all year round

Funding Type

PhD Type

Cells are subjected to a range of stresses that include physical injury, changes in oxygen levels or temperature, nutrient deprivation, radiation and infection.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.